Loading…

Antimicrobial activity studies on a trypsin–chymotrypsin protease inhibitor obtained from potato

A 5.6 kDa trypsin–chymotrypsin protease inhibitor was isolated from the tubers of the potato ( Solanum tuberosum L cv. Gogu) by extraction of the water-soluble fraction, dialysis, ultrafiltration, and C18 reversed-phase high performance liquid chromatography. This inhibitor, which we named potamin-1...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2005-05, Vol.330 (3), p.921-927
Main Authors: Kim, Jin-Young, Park, Seong-Cheol, Kim, Mi-Hyun, Lim, Hak-Tae, Park, Yoonkyung, Hahm, Kyung-Soo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 5.6 kDa trypsin–chymotrypsin protease inhibitor was isolated from the tubers of the potato ( Solanum tuberosum L cv. Gogu) by extraction of the water-soluble fraction, dialysis, ultrafiltration, and C18 reversed-phase high performance liquid chromatography. This inhibitor, which we named potamin-1 (PT-1), was thermostable and possessed antimicrobial activity but lacked hemolytic activity. PT-1 strongly inhibited pathogenic microbial strains, including Candida albicans, Rhizoctonia solani, and Clavibacter michiganense subsp. michiganinse. Automated Edman degradation showed that the N-terminal sequence of PT-1 was NH 2-DICTCCAGTKGCNTTSANGAFICEGQSDPKKPKACPLNCDPHIAYA-. The sequence had 62% homology with a serine protease inhibitor belonging to the Kunitz family, and the peptide inhibited chymotrypsin, trypsin, and papain. This protease inhibitor, PT-1, was composed of polypeptide chains joined by disulfide bridge(s). Reduced PT-1 almost completely lost its activity against fungi and proteases indicating that disulfide bridge is essential for its protease inhibitory and antifungal activity. These results suggest that PT-1 is an excellent candidate as a lead compound for the development of novel oral or other anti-infective agents.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2005.03.057